News

Earlier this month, the first set of data on post operative patient reported outcomes (PROMs) was published by the Department of Health (DH). For the first time, this has provided a patient-based assessment of changes in patients’ health related quality of life following hip replacement. The data also cover surgery on knees, varicose veins and groin hernias.

Obesity is an increasing challenge in England, as elsewhere. OHE has completed a study that examines PCT practice and the cost savings that could accrue if NICE guidance was followed more closely.

OHE Consulting makes the expertise of the team at the Office of Health Economics available to organisations in all sectors – public, private and voluntary. The consultancy has the knowledge and skills to address a wide range of issues in health care and pharmaceutical policy, economics and statistics.

Every country around the globe struggles with attaining an appropriate balance between providing affordable health care and ensuring access to medical advances. In a recent article in the British Journal of Clinical Pharmacology, Prof Adrian Towse examines the issues from a UK perspective. Managing and containing costs in the NHS is a perennial challenge. Far less clear is how to accomplish this while still ensuring sufficient incentives for timely access to new medical therapies, particularly new medicines.

Since 2007, new medications may be paid for by the statutory health insurance funds (GKV) in Germany only if they are cost-effective. Willingness-to-pay analyses can be essential background for decisions about the pricing and reimbursement of prescription medicines.

Pages